
Neurobiology of Bipolar Disorder
Road to Novel Therapeutics
- 1st Edition - November 25, 2020
- Imprint: Academic Press
- Editors: Joao L. de Quevedo, Andre Ferrer Carvalho, Eduard Vieta
- Language: English
- Paperback ISBN:9 7 8 - 0 - 1 2 - 8 1 9 1 8 2 - 8
- eBook ISBN:9 7 8 - 0 - 1 2 - 8 1 9 1 8 3 - 5
The Neurobiology of Bipolar Disorder: Road to Novel Therapeutics combines the basic neurobiology of bipolar disorder with discussions of the most recent advances in resear… Read more

Purchase options

Institutional subscription on ScienceDirect
Request a sales quote- Aids readers in understanding bipolar disorder in the context of NIMH Research Domain Criteria (RDoC) recommendations
- Covers a range of existing and potential pharmacologic and non-pharmacologic treatment options, from lifestyle adjustments to novel therapeutics
- Synthesizes a discussion of the cellular and molecular mechanisms underlying symptoms with clinical aspects of bipolar disorder
Advanced students and researchers in neuroscience, psychology, medicine, health sciences, and pharmacology
- Edition: 1
- Published: November 25, 2020
- Imprint: Academic Press
- No. of pages: 470
- Language: English
- Paperback ISBN: 9780128191828
- eBook ISBN: 9780128191835
JQ
Joao L. de Quevedo
Dr. João Luciano de Quevedo, MD, PhD, is a Professor of Psychiatry at the McGovern Medical School, the University of Texas Health Science Center at Houston, where he is the Vice-Chair for Faculty Development and Outreach, Director of the Translational Psychiatry Program, and Director of the Treatment-Resistant Depression Clinic. Before moving to Houston, he was a Dean at the University of Southern Santa Catarina Medical School, Criciúma, SC, Brazil, where he is still an Adjunct Professor of Psychiatry. He is also Editor-in-Chief of the Brazilian Journal of Psychiatry and Director of the Continuous Medical Education Program in Psychiatry (PROPSIQ) of the Brazilian Psychiatric Association. Dr. Quevedo’s research interest is neurobiology of psychiatric disorders, particularly mood disorders, and he is a specialist in both unipolar and bipolar treatment–resistant depression. He is author of nearly 600 publications and 10 scientific books.
AC
Andre Ferrer Carvalho
EV